Mark Gustafson, Director at Alzamend Neuro, Inc. (ALZN), sold 20,000 shares at $1.21 ($24K) on 2022-03-31, disclosed to the SEC on 2022-04-04.
Open-market sale of $24k ALZN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TPLM | BUY | 2008-09-15 | $10K | — | Filing → |
| TPLM | BUY | 2008-06-05 | $151K | — | Filing → |
| TPLM | BUY | 2007-11-02 | $5K | — | Filing → |